NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model

Lionel Larribere1,2, Huizi Wu1,2, Daniel Novak1,2

  • 1Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Insights

Neurofibromatosis type 1 (NF1) causes skin lesions. Researchers used patient stem cells to reveal that NF1 loss triggers senescence, impacting melanocyte differentiation and café-au-lait macule formation.

Area of Science:

  • Genetics
  • Developmental Biology
  • Cell Biology

Background:

  • Neurofibromatosis type 1 (NF1) is a common genetic disorder.
  • NF1 is characterized by neurofibromas and café-au-lait macules (CALMs).
  • The molecular basis of CALM development in NF1 is poorly understood.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying abnormal melanocyte differentiation in NF1.
  • To establish and utilize a human induced pluripotent stem cell (iPSC) model for NF1 research.

Main Methods:

  • Reprogramming of NF1 patient-derived fibroblasts into NF1(+/-) iPSCs.
  • Analysis of melanocyte differentiation from NF1(+/-) iPSCs.
  • Assessment of senescence in melanocytes and patient-derived CALMs.

Main Results:

  • NF1(+/-) iPSCs exhibit active RAS signaling.
  • NF1 loss leads to senescence during melanocyte differentiation.
  • Senescence is also observed in CALMs from NF1 patients.

Conclusions:

  • This study presents the first pathophysiological model of abnormal melanocyte differentiation in NF1 using human iPSCs.
  • NF1 loss plays a critical role in inducing senescence in the melanocyte lineage.
  • These findings uncover a novel function of NF1 in melanocyte development and CALM formation.